Details of Bacterial Vaccine
This bacterial vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 1265 |
| Name of the vaccine | GC3111 |
| Microbe | Bacteria |
| Disease name | Diphtheria |
| Name of bacteria | Corynebacterium diphtheriae |
| Type of vaccine | Combination |
| Nucleic acid content | DNA |
| Age | 19 to 64 years |
| Description of the vaccine | Tdap vaccine. |
| Name of the manufacturer | Green Cross Corporation |
| Name of the manufacturing country | Korea, Republic of |
| Year of manufacture | 2021 |
| Clinical Phase status | Clinical - Phase 2 |
| Bacterial strain | Gram-positive bacillus. |
| Efficacy | NA |
| Vaccine formulation | Suspension for injection |
| Dosage | Single dose. |
| Mechanism of action | Antibody response against filamentous hemagglutinin (FHA). |
| Route of administration | Intramuscular |
| Indications | NA |
| Export | NA |
| Approval | NA |
| Adjuvant | NA |
| Repurposing | For tetanus and pertussis. |
| Side effects of vaccine | NA |
| Post vaccination | NA |
| Dose type | Single dose |
| Interspecies transfer | NA |
| PubMed identifier | 34641798 |
| Clinical trial number | NCT04238975 |
| Reference | NA |
| Other name | NA |
| Additional Links | NA |